RH-34

From WikiMD's WELLNESSPEDIA

RH-34 is a psychoactive drug that belongs to the phenethylamine class of compounds. It is also known as 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine. RH-34 is a derivative of 2C-I and is often used in research for its psychedelic properties.

History[edit]

RH-34 was first synthesized in the late 20th century by a team of chemists led by Alexander Shulgin. Shulgin's work on the synthesis and effects of RH-34 and other phenethylamines is documented in his book PiHKAL.

Pharmacology[edit]

The exact mechanism of action of RH-34 is not fully understood. However, it is believed to act as a serotonin receptor agonist, similar to other psychedelic phenethylamines. This means that it binds to and activates certain serotonin receptors in the brain, leading to its psychedelic effects.

Effects[edit]

The effects of RH-34 can vary greatly depending on the dose, the individual's physiology, and the context in which it is used. Common effects reported by users include visual hallucinations, altered thought processes, and heightened emotional sensitivity. Some users also report physical effects such as increased heart rate and blood pressure.

Legal Status[edit]

The legal status of RH-34 varies by country. In some countries, it is classified as a controlled substance, making its possession, sale, or use illegal. In other countries, it is legal to possess and use RH-34 for research purposes.

See Also[edit]





RH-34[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.